Clinical chronic pancreatitis.
Clinical chronic pancreatitis.
复制标题
DOI:
10.1097/mog.0000000000000293
复制
发表时间:
2016-09
影响因子:
2.5
通讯作者:
Park WG
中科院分区:
文献类型:
--
作者:
Park WG
To summarize observations in clinical chronic pancreatitis (CP) in the past year. A predisposing genetic mutation was identified in 67% of cases of pediatric chronic pancreatitis. A novel susceptibility gene involving a hybrid allele (CEL-HYB) is associated with idiopathic CP. ABO blood type B and FUT2 non-secretor status is associated with asymptomatic hyperlipasemia and chronic pancreatitis. Alcohol consumption impairs CFTR activity leading to decreased bicarbonate secretion and patients with susceptible CFTR mutations can develop clinical pancreatitis. CT imaging findings in CP correlate poorly with pain patterns. EUS features correlate poorly with fibrosis. Circulating epithelial cells are present in CP patients but not healthy volunteers. Surgery is superior to endoscopic treatment in providing durable pain relief (> 5 years). Repetitive pancreatic duct stent placements and chronic narcotic use are pre-operative predictors of poor outcome after total pancreatectomy with islet cell auto transplantation (TPIAT). Novel genetic mutations for idiopathic chronic pancreatitis are being identified. Alcohol impairs CFTR activity and may explain a mechanism for pancreatitis. Current imaging modalities correlate poorly with clinical pain presentation and fibrosis in CP. Novel imaging modalities are needed. As TPIAT grows, rigorous outcomes analysis is needed to drive patient selection.